Thomas Ciulla - 05 Feb 2024 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VRDN	Stock Option (Right to Buy)	Award	$0	+50,000		$0.000000	50,000	05 Feb 2024	Common Stock	50,000	$18.70	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests in 48 equal monthly installments, subject to the Reporting Person's continued service to Issuer through each vesting date.